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Summary Background: Primary hyperparathyroidism is a prevalent disease with proven ben-
efits for appropriately selected patients who undergo parathyroidectomy. The ability to accu-
rately predict expected single adenoma gland weight as the cause based on preoperative
biochemical tests could improve cure rates in a minimally invasive approach.
Objective: To assess the correlation between parathyroid weight and preoperative parathyroid
hormone and calcium levels in patients with primary hyperparathyroidism with a solitary ade-
noma and determine if these could be used to predict expected parathyroid weight.
Methods: Patients with primary hyperparathyroidism who underwent curative parathyroidec-
tomy from 2013 to 2018 was retrospectively analysed.
Results: There is a strong positive correlation rZ 0.602 between preoperative PTH levels with
respect to parathyroid weight (p < 0.001). There was a moderate correlation r Z 0.474 be-
tween preoperative adjusted Calcium and PTH weight (p < 0.001). An algorithm was developed
to calculate predicted weight of a single adenoma but when tested against cases with hyper-
plasia and double adenomas during the period, the variability of predicted weight meant it was
impossible to differentiate between the causes. Hyperplasia was excluded and 95% of double
adenomas excluded however, when parathyroid weight exceeded 1200 mg
Conclusion: There is a strong correlation between preoperative PTH levels and calcium levels
with parathyroid weight. The large variability of predicted parathyroid weight however, pre-
cludes the use of biochemical tests alone preoperatively in being able to differentiate between
a s ing le adenoma, double adenoma or hyperp las ia as the cause in pr imary
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hyperparathyroidism. At parathyroid predicted weights above 1200 mg however, all cases of
hyperplasia, and 95% of double adenomas excluded.
ª 2019 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Primary Hyperparathyroidism (PHPT) is a prevalent disease
in the population at 7 cases per 1000 adults.1 A solitary
parathyroid adenoma is the cause in most cases (85e90%)
with the remaining being multiple adenomas, hyperplasia
and rarely carcinoma. Most people (85e90%) have four
parathyroid glands each of mean total weight
29.5e62.4 mg.2,3 Normal gland dimensions are 3e6 mm
(length) by 2e4 mm (width) and 0.5e2 mm (thickness).4
Primary Hyperparathyroidism (PHPT) is commonly associ-
ated with renal calculi, osteopenia, osteoporosis, con-
stipation and other mental side effects.
The benefits of curative parathyroidectomy are well
documented with the highest chance of cure at the index
operation.5 In re-explorations, there is considerable in-
crease in morbidity with a decreased chance of cure.6 Thus,
the ability to predict the minimum expected weight of the
gland accurately could be valuable to the operating surgeon
in a minimally invasive approach. The correlation between
preoperative calcium, PTH levels and parathyroid adenoma
weight remains indeterminate. Some studies report a sta-
tistically significant correlation between preoperative cal-
cium, PTH and parathyroid weight7e10 whereas others
dispute the finding.11,12 Many of these papers published
consist of small numbers which may account for the vari-
able findings. This study aimed to investigate the correla-
tion between preoperative calcium and PTH levels with
respect to parathyroid histological weight and volume and
analyse its ability to predict single adenoma weight as the
cause in primary HPT with a large database.
1.1. Ethical considerations
Ethical approval was obtained through the Ethics Commit-
tee via St John of God Hospital.
2. Methods
Data entered prospectively was analysed retrospectively
from the Western Australian Endocrine Database from
January 2013 to December 2018 from three surgeons. All
patients underwent a parathyroidectomy with either a
bilateral cervical exploration or minimally invasive
approach. All patients had histological confirmation of a
single adenoma with parathyroid weight obtained from
histological records. Preoperative peak PTH and Calcium
levels were used in the analysis. Initially 621 patients were
identified. Patients who had double adenomas, gland hy-
perplasia, parathyroid carcinoma, recurrent or persistent
hyperparathyroidism were then excluded from the initial
analysis. After applying exclusion criteria and patients with
incomplete blood tests, a total of 555 patients were
included for analysis.
2.1. Statistical analysis
Exploratory data analysiswas initially conducted. Descriptive
statistics for each of the variables of interests were given by
mean and standard deviation (SD), along with the minimum
and maximum values. Correlation and linear regression
analyses were conducted to ascertain the relationship
between parathyroid (PT) weight (mg) as a dependent vari-
able with calcium (mmol/L) and parathyroid hormone (PTH)
levels (pmol/L) as instrumental variables including age as
a confounding variable. Scatter plots were used to examine
the nature of the relationship between the instrumental
variables with PTweight visually. Log-transformed PTweight
and PTH level were used in the models. There was a
logelinear relationship between the variables.
The association between each of the instrumental vari-
ables (IVs) with PT weight was initially investigated with
simple linear regression modelling. The significance of the
IVs was then examined simultaneously using a multivariable
linear regression model. All analyses were conducted using
IBM SPSS. Statistical significance was defined as p  0.05.
3. Results
A total of 555 patients were included for statistical anal-
ysis. The summary statistics for PT weight and the relevant
predictors are given in Table 1. Fig. 1 and Fig. 2 illustrate
the bivariate relationship between PTH level with PT
weight and calcium. The variability in PT weight increased
with PTH level, especially when PTH exceeded 50 (Fig. 1).
This behaviour for PTweight was also evident when calcium
level exceeded 3 mg/dL. Nevertheless, PT weight had a
linear relationship to PTH levels and calcium.
The results for the correlation and regression analyses
are presented in Table 2. Both univariable and multivari-
able analyses show that PTH level and calcium are signifi-
cantly and linearly associated with PT weight (p < 0.01),
where PTH and calcium levels increased with increasing PT
Table 1 Summary statistics of the relevant DV and IVs.
Variable Mean (SD) Range (min, max)
PT Weight 1022 (2310) (38, 31700)
PTH Level 17.9 (23.3) (4.5, 369.2)
Calcium 2.71 (0.21) (2.26, 3.91)
Age in years 63.3 (13.6) (17, 93)
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weights. Of the two predictors, PTH level has a stronger
correlation with PT weight than calcium. Age was found to
be negatively associated with PT weight.
Fig. 3 provides a visual diagnostic of the multivariable
model. The scatterplot demonstrates strong significant
correlation (Pearson r Z 0.602, p < 0.001) between
observed PT weights and the PT weight estimates from the
multivariable model. The residual plot (right) illustrates
normal behaviour from the residuals.
Based on the data and analysis, we developed an algo-
rithm (PT Weight Z Exp (1.8581 þ 0.86213*Ln (PTH
level) þ 1.0159*Calcium e 0.01096*Age) that would calcu-
late the expected weight as well as minimum weight for a
solitary adenoma based on preoperative calcium and PTH
levels (CI 95% p < 0.001) (Fig. 3). The formula was then
tested against all cases of hyperplasia and double adenomas
during the same time period. A total of 71 (10.3%) double
adenoma and 63 (9.2%) hyperplasia cases were identified.
These were plotted in the multivariate regression model and
ROC analysis conducted (Fig. 4). With an AUC Z 0.506, the
predicted PTweights had no capacity to distinguish between
single adenoma and double adenoma (Fig. 5). However,
there was moderate ability to distinguish single adenoma
from hyperplasia (AUC Z 0.691). A specificity of 95% was
achieved at the cut-off of PT weight at 759 mg with a pre-
dictive positive value (PPV) of 97%. Furthermore, if PT gland
weight was greater than 1200 mg, 95% of double adenomas
and 100% of hyperplasia cases were excluded.
4. Discussion
Previous research exploring the relationship between pre-
operative biochemical results and parathyroid weight have
concluded with discrepant findings. We analysed 555 pa-
tients and demonstrate a strong positive correlation 0.557
between preoperative PTH levels with respect to para-
thyroid weight (p < 0.001). There was a moderately sig-
nificant correlation 0.466 between preoperative adjusted
Calcium and PTH weight (p < 0.001). The correlation of
parathyroid weight with PTH levels was stronger than
adjusted calcium with an overall strong Pearson correlation
at 0.602 (p < 0.001). Bindish et al described a positive
correlation between single adenoma weight and volume.8
Figure 1 Scatter plot of PT weight vs PTH, untransformed (left) and log-transformed (right). The broken red line represents the
regression line.
Figure 2 Scatter plot of the untransformed (left) and log-transformed (right) PT weight vs Calcium. The broken red line rep-
resents the regression line.
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Moretz et al found a positive correlation between intra-
operative PTH and parathyroid weight only when the PTH
levels were high or low.9 Kamani et al looking at 69 patients
demonstrated a positive correlation between PTH weight
and preoperative PTH levels and calcium but not phos-
phate.10 Other studies which looked at 40e77 patients
showed no correlation between preoperative biochemical
results and parathyroid weight or volume.11,12 The largest
study by Stern et al looking at 371 patients found a signif-
icant correlation between preoperative PTH level, preop-
erative calcium with parathyroid weight and volume.7 This
article was also unique as they examined the possible cor-
relation between chief cell proportion histologically and
PTH level but found no statistically significant correlation.7
Parathyroid weight and percentage of functional cells.13
The variability of a parathyroid adenoma weight for a given
PTH level can be affected by fibrosis, calcification, hae-
morrhage and cystic degeneration.14 The proportion of
functional cells is also a potential reason for the large
variability in weight for a given PTH level.7 Apart from
percentage of functional cells, another theory for vari-
ability in PTH weight is vitamin D deficiency. Vitamin D
deficiency has been described to result in heavier adeno-
masBased on these findings, we initially developed an al-
gorithm to calculate expected parathyroid weight of a
single adenoma as a cause based on preoperative
biochemical calcium and PTH levels. Being able to predict
expected weights could be useful particularly where
intraoperative parathyroid hormone measurement (ioPTH)
is not utilised routinely. It has been well documented that
an appropriate ioPTH fall increases surgical curative rates
particularly in a minimally invasive approach.15 Intra-
operative PTH is not routinely performed in our surgical
centres and most of Australia and New Zealand due to a
slow turnover time. Unfortunately, when we simultaneously
analysed patients with hyperplasia and double adenomas
within the same time period with the algorithm, it was
impossible to differentiate between the three based on
predicted weight (Fig. 4). The significant finding however,
was that at parathyroid predicted weights above 1200 mg,
all cases of hyperplasia were excluded and 95% of double
adenomas excluded.
In this study, we found that variability of predicted PT
weight increased with higher preoperative PTH and calcium
levels. This variability in predicted PT weights accounts for
the difficulty in accurately predicting intraoperative weight
despite strong linear correlation on a regression model. One
of the causes of variability is.16
This study is limited by its retrospective design, rela-
tively small sample size and that we defined cure as a sig-
nificant drop postoperatively to a low normal PTH level as
well as normal calcium and parathyroid hormone level at
two weeks postoperatively. We were unable to account for
repeated tests for the majority of these patients at 6
Table 2 Univariable and multivariable linear regression modelling of log-transformed PT weight with PTH level, calcium and
age.
Univariablea Multivariableb
Predictor Correlation Estimate (95% CIc) p-value Partial Correlation Estimate (95% CIc) p-value
Ln (PTH Level) 0.557 0.99 (0.87, 1.11) <0.001 0.402 0.75 (0.61, 0.89) <0.001
Calcium 0.466 2.37 (1.99, 2.75) <0.001 0.238 1.20 (0.79, 1.61) <0.001
Aged 0.138 0.05 (0.09, 0.02) 0.001 0.160 0.05 (0.08, 0.02) <0.001
a Ln (PT weight) was modelled against each predictor independently of the others.
b Ln (PT weight) was modelled against all the predictors simultaneously. Adjusted Rb Z 0.359.
c CI Z Confidence interval.
d Estimate and 95% CI for Age are given for every 5-year increment.
Figure 3 Scatterplot (left) of the observed PT weights and the multivariable model estimates and the residual plot (right). The
broken red line on the scatterplot represents the model estimates with the solid lines representing the 95% prediction interval.
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months. We acknowledge that up to 3e5% of persistent
hyperparathyroidism could potentially be missed in this
scenario.17 All of these patients however have not had re-
operations registered in the database, which encompasses
the majority of parathyroid surgery done in Western
Australia. Another limitation is that the labs that test for
PTH vary in using either Centaur or Roche for analysis. The
intervals for PTH used by Centaur is 1.9e8.5 pmol/L and
Roche 1.6e6.9 pmol/L.
5. Conclusions
This study shows that there is a strong positive correlation
between PTH weight and preoperative PTH Levels and a
moderate positive correlation to preoperative calcium
levels. The variability of parathyroid weight however, pre-
cludes the use of biochemical tests alone preoperatively in
being able to differentiate between a single adenoma,
double adenoma or hyperplasia as the cause in primary
hyperparathyroidism. At parathyroid predicted weights
above 1200 mg, all cases of hyperplasia, and 95% of double
adenomas excluded.
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